Teitur Trophics

Teitur develops novel therapeutics for treating or preventing neurodegenerative diseases.

Teitur is Old Norse for happiness. Teitur’s ambition and commitment is to create new treatments for patients suffering from neurodegenerative diseases to help them live a longer, better and happier life.

From the Sortilins family of receptors, Teitur has developed cyclic peptides with a unique potential for addressing key pathologies across several neurodegenerative disorders including Huntington’s Disease, Parkinson’s Disease and Frontotemporal Dementia. These diseases impact memory, behaviour, movement and mood of millions of people around the globe and Teitur strives to improve the lives of these patients.


For more information, please contact:

Søren Lemonius, Msc

Managing General Partner

Phone: +45 4081 4889